SEC Form 4 · accession 0001140361-16-046894
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E I Pyott
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2016 | A | 2,100 | $0.00 | A | 2,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2 | $104.92 | Jan 4, 2016 | A | 6,100 | A | Jan 4, 2017 | Jan 3, 2026 | Common Stock | 6,100 | 6,100 | D |
Explanation of responses
- F1Restricted Stock units granted on January 4, 2016. Price not applicable.
- F2Original option grant vests annually over three years.